Academia
On this page, you will find information on the European Medicines Agency’s (EMA) activities that are most relevant to academia, including news and events. Learn more about the Agency's resources to support medicine development:
Human regulatory: Research and development
Veterinary regulatory: Research and development
Learn more about how EMA interacts with academia.
Featured information
-
List item
Public consultation on draft framework for paediatric clinical trial preparedness
The European Network of Paediatric Research at the European Medicines Agency invites all stakeholders involved in paediatric clinical trials to provide comments on its draft framework on paediatric clinical trial preparedness by writing to enpremasurveys@ema.europa.eu, by 15 November 2019. The aim of this consultation is to identify potential gaps and present a more comprehensive view.
-
List item
The journey of a centrally authorised medicine
EMA's new booklet describes the journey of a medicine for human use authorised via EMA, from initial research to discussions on patient access to medicines across the EU. This includes how EMA supports medicine development by providing scientific advice and how it assesses a medicine’s benefits and risks once it receives an application for marketing authorisation.
-
List item
European Reference Networks
European Reference Networks (ERNs) are virtual networks involving healthcare providers across Europe. They aim to facilitate discussion on complex or rare diseases and conditions that require highly specialised treatment and concentrated knowledge and resources. Information videos and flyers are available for patients and healthcare professionals on the European Commission’s website.
-
List item
Use of patient registries
The cross-committee task force on patient registries published a discussion paper on methodological and operational considerations in the use of patient disease registries for regulatory purposes. Interested parties can send their comments and suggestions or an annotated version of the document by 30 June 2019.
-
List item
Horizon 2020 research funding
EMA has published a dedicated webpage with information that may be helpful for researchers applying for funding under the European Commission's Horizon 2020 programme in the area of health.
-
List item
Supporting medicine developers
EMA's infosheet highlights the regulatory tools EMA offers to support the development of new and innovative medicines – from the early phases in the laboratory all the way to the patient.